[1] Carlsson L,Röstlund T,Albrektsson B,et al.Osseointegration of titanium implants. Acta Orthop Scand.1986;57(4):285-289.
[2] Joos U, Kleinheinz J. Reconstruction of the severely resorbed (Class VI) jaws: routine or exception?J Craniomaxillofac Surg.2000;28(1): 1-4.
[3] Balk SD.Calcium as a regulator of the proliferation of normal, but not of transformed, chicken fibroblasts in a plasma-containing medium. Proc Natl Acad Sci USA. 1971;68(2): 271-276.
[4] Hildner F, Albrecht C, Gabriel C, et al. State of the art and future perspectives of articular cartilage regeneration: a focus on adipose-derived stem cells and platelet-derived products. J Tissue Eng Regen Med. 2011;5(4):e36-51.
[5] Lee KS, Wilson JJ, Rabago DP, et al.Musculoskeletal applications of platelet-rich plasma: fad or future? AJR Am J Roentgenol.2011; 196:628–636
[6] Raghoebar GM, Schortinghuis J, Liem RS, et al.Does platelet-rich plasma promote remodeling of autologous bone grafts used for augmentation of the maxillary sinus floor?. Clin Oral Implants Res.2005;16(3): 349-356.
[7] Por YC, Barceló CR, Salyer KE, et al. Bone generation in the reconstruction of a critical size calvarial defect in an experimental model.J Craniofac Surg.2008;19(2): 383-392.
[8] Urist MR,Strates BS.Bone morphogenetic protein.J Dent Res.1971;50(6): 1392-1406.
[9] Reichert JC, Woodruff MA, Friis T, et al.Ovine bone- and marrowderived progenitor cells and their potential for scaffold-based bone tissue engineering applications in vitro and in vivo. J Tissue Eng Regen Med.2010;4:565-576.
[10] De Biase P, Capanna R. Clinical applications of MBP. Injury. 2005;36(Suppl 3):S43-S46.
[11] Deschaseaux F, Sensebe L, Heymann D . Mechanisms of bone repair and regeneration. Trends Mol Med.2009;15: 417-429.
[12] Wallace AL, Makki R, Weiss JB, et al. Measurement of serum angiogenic factor in devascularized experimental tibial fractures. J Orthop Trauma.1995;9(4): 324-332.
[13] Carreira AC1, Lojudice FH, Halcsik E, et al. Bone morphogenetic proteins: facts, challenges, and future perspectives. J Dent Res.2014;93(4):335-380.
[14] Ali IH, Brazil DP. Bone morphogenetic proteins and their antagonists: current and emerging clinical uses. Br J Pharmacol.2014;171(15):3620-3652.
[15] Boerckel JD, Kolambkar YM, Dupont KM, et al. Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials.2011;32: 5241-5251.
[16] Karsenty G. The complexities of skeletal biology. Nature. 2003; 423: 316-318.
[17] Nakamura J, Yanagita M. Bmp modulators in kidney disease. Discov Med.2012; 13: 57-63.
[18] Wang EA, Rosen V, D'Alessandro JS,et al.Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci U S A.1990;87(6): 2220-2224.
[19] Nakahara H, Takaoka K, Koezuka M, et al.Periosteal bone formation elicited by partially purified bone morphogenetic protein. Clin Orthop Relat Res.1989;(239): 299-305.
[20] Kim CS, Kim JI, Kim J, et al. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials.2005;26(15): 2501-2507.
[21] Degat MC, Ferreira E, Logeart-Avramoglou D. Use of growth factors in the repair of bone. Pathol Biol (Paris). 2005;53: 131-141.
[22] Ben-David D, Srouji S, Shapira-Schweitzer K, et al. Low dose BMP-2 treatment for bone repair using a PEGylated fibrinogen hydrogel matrix. Biomaterials. 2013;34:2902-2910.
[23] Winn SR, Uludag H, Hollinger JO. Carrier systems for bone morphogenetic proteins. Clin Orthop Relat Res.1999; 367 (Suppl):95-106.
[24] Yang X, Han G, Pang X, et al. Chitosan/collagen scaffold containing bone morphogenetic protein-7 DNA supports dental pulp stem cell differentiation in vitro and in vivo. J Biomed Mater Res A. 2012; Feb 18. doi: 10.1002/jbm. a.34064. [Epub ahead of print]
[25] Polimeni G, Koo KT, Pringle GA, et al. Histopathological observations of a polylactic acid-based device intended for guided bone/tissue regeneration. Clin Implant Dent Relat Res.2008;10:99-105.
[26] Cestari TM, Granjeiro JM, de Assis GF,et al. Bone repair and augmentation using block of sintered bovine-derived anorganic bone graft in cranial bone defect model. Clin Oral Implants Res.2009;20:340-350.
[27] Salgado PC, Sathler PC, Castro HC, et al. Bone remodeling, biomaterials and technological applications: revisiting basic concepts.J Biomater Nanobiotechnol.2011;2:318-328.
[28] Hagi TT, Wu G, Liu Y, et al. Cell-mediated BMP-2 liberation promotes bone formation in a mechanically unstable implant environment. Bone.2010;46:1322-1327.
[29] Berner A, Boerckel JD, Saifzadeh S, et al. Biomimetic tubular nanofiber mesh and platelet rich plasma-mediated delivery of bmp-7 for large bone defect regeneration. Cell Tissue Res. 2012;347(3):603-615.
[30] 罗应伟,李松,沈丽宁. BMP-4 mRNA在Meckel’s软骨中的表达及意义.[J].昆明医学院学报,2004;25(3):9-12.
[31] Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury. 2005;36(12): 1392-1404.
[32] Gale NW, Yancopoulos GD. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 1999;13(9):1055-1066.
[33] Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet- derived growth factor and its involvement in disease. Mayo Clin Proc.2006;81(9):1241-1257.
[34] Conover CA. In vitro studies of insulin-like growth factor I and bone. Growth Horm IGF Res. 2000; 10 Suppl B:S107-10. Review.
[35] Canalis E. Effect of insulinlike growth factor I on DNA and protein synthesis in cultured rat calvaria. J Clin Invest. 1980; 66(4):709-719.
[36] Tanaka H, Quarto R,Williams S,et al.In vivo and in vitro effects of insulin-like growth factor-I (IGF-I) on femoral mRNA expression in old rats. Bone.1994; 15(6):647-53.
[37] Meraw SJ, Reeve CM, Lohse CM,et al.Treatment of peri-implant defects with combination growth factor cement. J Periodontol.2000;71(1):8-13.
[38] Sipe JB, Zhang J, Waits C, et al.Localization of bone morphogenetic proteins (MBP)-2,-4, and -6 within megakaryocytes and platelets. Bone.2004;35(6):1316-1322.
[39] Glowacki J. Angiogenesis in fracture repair. Clin Orthop Relat Res.1998;(355 Suppl): S82-89. 23.
[40] Salim A, Nacamuli RP, Morgan EF,et al.Transient changes in oxygen tension inhibit osteogenic differentiation and Runx2 expression in osteoblasts. J Biol Chem.2004;279(38): 40007-40016. |